To incorporate a quorum sensing blocker (lactams) into wound dressing platforms to control biofilms
The general aim of this proof of concept of study is to develop and evaluate a pioneering wound dressing to be used as a new, smart technology for the effective management of biofilms in wounds, which has the potential to greatly enhance patient outcomes and reduce healthcare costs.
Collaboration between 5D, The University of Liverpool, Penrhos Bio and Unilever